Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination
Recruiting
N/A
Interventional Study
Onchocerciasis
Loiasis
Mansonelliasis
Healthy Volunteers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 400 (estimated)
- Sponsor
- Bioaster · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Onchocerciasis, also known as river blindness, is one of the disease targeted for elimination by the World Health Organization (WHO) in the group of Neglected Tropical Diseases. Existing diagnostic tools for onchocerciasis have limitations that make mapping, epidemiological assessments and verification of elimination of onchocerciasis difficult. It is in this context that WHO, in its 2021-2030 roa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects informed of the objectives of the study and who signed a consent form
* Subjects without filariasis (for control subjects), or
* Subjects mono-infected with Onchocerca volvulus, or
* Subjects mono-infected with Loa loa, or
* Subjects mono-infected with Mansonella pers…
Contacts